(PharmaNewsWire.Com, March 31, 2017 ) Market Data Forecast recently published a report on the North America Cancer Immunotherapy Market which estimates the market to grow from USD 28.2 billion from 2016 to USD 50.71 billion in 2021 with a high CAGR of 12.20%.
Immunotherapy is a kind of treatment used to cure the cancer by increasing bodys natural defences to kill cancer cells . It also assists in improving the immune system function by the components in the body from laboratory. It also helps in inhibiting growth of cells related to cancer.
The DROC Analysis contains some of the factors that have major effects on the market dynamics be it positive or negative. Few factors analysed in the section Changing life style, increasing occurrence of cancer, excessive alcoholic intake and Smoking, radiation therapies, Cost of cancer therapies, limited information on cancer immunobiology high efficacy of immunotherapy compared to other treatments, reduced chance of recurrence of cancer, less side effects associated with cancer immunotherapy, radiation therapies,limited information on cancer immunobiology
The treatments are segmented based on type, application, administration and end user and studied for a deep-level understanding of the Diagnostic Imaging market. Each sub segment is accompanied with Market Size Estimations and Y-o-Y Forecasts as well.
Market Segmentation:
Based on Application:
Breast
Lung
Melanoma
Colorectal
Head & Neck
Prostate
others
Based on Product Type:
Monoclonal Antibodies
Checkpoint inhibitors/immune modulators
Therapeutic cancer vaccines
Oncolytic virus immunotherapy
Cytokines
Adoptive T cell transfer
Adjuvant Immunotherapy
Interferons
Interleukins
BCG
Others
Based on Mode of Administration:
Intravenous
Oral
Topical
Intravesical
Based on End users:
Hospitals
Clinics
North American Market is studied in geographic perspective by segregating the market shares between USA and Canada.
As per the report, companies like are F. Amgen, Viralytics, Pfizer, GlaxoSmithKline Pharmaceuticals Limited, Novartis Pharmaceuticals Corporation, Hoffmann-La Roche Ltd, AstraZeneca plc, Advaxis, Bristol-Myers Squibb, Medivation,Merck & Co. and Celgene Corp, Immunomedics.
Scope of the North America Cancer Immunotherapy Market:
Regional and country-level analysis that provides an innate perspective of USA and Canada Market to that of the North American region
To detect major focus areas of industrial growth Segment-level analysis on basis of type, application,administration and end-user along with market size forecasts and y-o-y estimations are provided
Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics
PESTLE and Porters Five Forces Analyses that examine themacro & micro environmental factors such as political influence, technological prowess, industry rivalry to name a few.
Anextensive listing of major market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview to study and sustain the market environment
mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies all rolled out into Competitive landscape
Expertly devised Market Outlookcomprising the Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Therapeutics Segment :
The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the clients research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
